Treatment of Advanced Non–Small Cell Lung Cancer in 2018
Authors:
- 1 April 2018
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 4 (4) , 569-570
Abstract
This Insights characterizes recent advances and describes a framework for the treatment of advanced non–small cell lung cancer.Keywords
This publication has 3 references indexed in Scilit:
- Faculty Opinions recommendation of Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.2018
- Faculty Opinions recommendation of Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.2018
- Faculty Opinions recommendation of Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.2015